EMCDDA Home
  • EN
Search

Report on the risk assessment of 5-(2-aminopropyl)indole in the framework of the Council Decision on new psychoactive substances

EMCDDA, Lisbon, January 2014

Publication type:

Risk assessments

Summary:

This report presents the data and findings of the risk assessment on the new psychoactive substance, 5-(2-aminopropyl)indole, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant drug in the European Union led to an assessment of the health and social risks posed by the substance, and, consequently,
its control across the EU Member States.

Download as pdf (923Kb):

English (en)

Table of contents

  • Foreword
  • Introduction
  • EMCDDA actions on monitoring and responding to new drugs
  • EMCDDA–Europol Joint Report on 5-(2-aminopropyl)indole: a summary
  • Risk Assessment Report of a new psychoactive substance: 5-(2-aminopropyl)indole
  • Annex 1: Technical report on 5-(2-aminopropyl)indole
  • Annex 2: Study examining the inhibition of human monoamine oxidase (MAO) by the new psychoactive substance 5-(2-aminopropyl)indole (5-IT)
  • Council Implementing Decision 2013/496/EU on subjecting 5-(2-aminopropyl)indole to control measures
  • Abbreviations
  • Participants of the risk assessment meeting

Pages:

50

Price:

free

ISBN/ISSN:

978-92-9168-672-8

Catalogue number:

TDAK13002ENN

Page last updated: Monday, 24 February 2014